Ad is loading...
NVYTF
Price
$0.66
Change
-$0.00 (-0.00%)
Updated
Nov 8 closing price
PCHM
Price
$3.15
Change
-$0.07 (-2.17%)
Updated
Nov 15 closing price
Ad is loading...

NVYTF vs PCHM

Header iconNVYTF vs PCHM Comparison
Open Charts NVYTF vs PCHMBanner chart's image
Novacyt Clamart
Price$0.66
Change-$0.00 (-0.00%)
Volume$245
CapitalizationN/A
PharmChem
Price$3.15
Change-$0.07 (-2.17%)
Volume$1.14K
CapitalizationN/A
NVYTF vs PCHM Comparison Chart
Loading...
View a ticker or compare two or three
VS
NVYTF vs. PCHM commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVYTF is a Hold and PCHM is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NVYTF: $0.66 vs. PCHM: $3.15)
Brand notoriety: NVYTF and PCHM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVYTF: 41% vs. PCHM: 25%
Market capitalization -- NVYTF: $56.79M vs. PCHM: $17.56K
NVYTF [@Medical Specialties] is valued at $56.79M. PCHM’s [@Medical Specialties] market capitalization is $17.56K. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVYTF’s FA Score shows that 0 FA rating(s) are green whilePCHM’s FA Score has 1 green FA rating(s).

  • NVYTF’s FA Score: 0 green, 5 red.
  • PCHM’s FA Score: 1 green, 4 red.
According to our system of comparison, PCHM is a better buy in the long-term than NVYTF.

Price Growth

NVYTF (@Medical Specialties) experienced а 0.00% price change this week, while PCHM (@Medical Specialties) price change was -7.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
NVYTF($56.8M) has a higher market cap than PCHM($17.6K). PCHM YTD gains are higher at: 29.959 vs. NVYTF (-11.374). PCHM has higher annual earnings (EBITDA): 1.01M vs. NVYTF (-1.71M). NVYTF has less debt than PCHM: NVYTF (1.87M) vs PCHM (4.8M). NVYTF has higher revenues than PCHM: NVYTF (95.8M) vs PCHM (27.6M).
NVYTFPCHMNVYTF / PCHM
Capitalization56.8M17.6K322,727%
EBITDA-1.71M1.01M-169%
Gain YTD-11.37429.959-38%
P/E Ratio1.33N/A-
Revenue95.8M27.6M347%
Total Cash102MN/A-
Total Debt1.87M4.8M39%
FUNDAMENTALS RATINGS
PCHM: Fundamental Ratings
PCHM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTEX28.83-0.11
-0.38%
Open Text Corp
AMN23.70-0.17
-0.71%
AMN Healthcare Services
CLEU0.21N/A
-1.90%
China Liberal Education Holdings Limited
KRT29.48-0.80
-2.64%
Karat Packaging
AREC0.90-0.14
-13.34%
American Resources Corp

NVYTF and

Correlation & Price change

A.I.dvisor tells us that NVYTF and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVYTF and ARAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVYTF
1D Price
Change %
NVYTF100%
N/A
ARAY - NVYTF
31%
Poorly correlated
-2.30%
MBGNF - NVYTF
28%
Poorly correlated
N/A
PRCT - NVYTF
21%
Poorly correlated
+3.53%
NUMD - NVYTF
10%
Poorly correlated
-5.37%
ODYY - NVYTF
8%
Poorly correlated
-13.51%
More

PCHM and

Correlation & Price change

A.I.dvisor tells us that PCHM and INSP have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCHM and INSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCHM
1D Price
Change %
PCHM100%
-2.17%
INSP - PCHM
24%
Poorly correlated
-0.13%
OTCFF - PCHM
20%
Poorly correlated
-8.33%
NVYTF - PCHM
7%
Poorly correlated
N/A
PYNKF - PCHM
5%
Poorly correlated
+2.16%
OSSUY - PCHM
4%
Poorly correlated
N/A
More